Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Aradigm Corporation (ARDM)

1.33 -0.05 (-3.62%)

08-15 15:51

Open:

1.35

Pre. Close:

1.38

High:

1.375

Low:

1.27

Volume:

25,007

Market Cap:

19M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.382 - 1.388

1.388 - 1.395

Low:

1.251 - 1.259

1.259 - 1.267

Close:

1.315 - 1.328

1.328 - 1.341

Technical analysis  (as of: 2018-08-15 4:30:45 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 1.75     One year: 1.92

Support:

Support1: 1.27    Support2: 1.06

Resistance:

Resistance1: 1.50    Resistance2: 1.64

Pivot:

1.40

Moving Averages:

MA(5): 1.38     MA(20): 1.41

MA(100): 1.45     MA(250): 2.35

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 20.83     %D(3): 26.06

RSI:

RSI(14): 39.13

52-Week:

High: 7.35  Low: 1.03  Change(%): 3.9

Average Vol(K):

3-Month: 4717  10-Days 1323

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ARDM has closed above bottom band by 2.1%. Bollinger Bands are 60.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to ARDM's normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-08-14T08:07:51-04:00
Aradigm misses by $0.03, beats on revenue

2018-08-14T08:00:00-04:00
Aradigm Announces Second Quarter 2018 Financial Results

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

15.21

Shares Float (M)

11.83

% Held by Insiders

22.20

% Held by Institutions

27.40

Shares Short (K)

285

Shares Short Prior Month (K)

Stock Financials

EPS

-0.790

EPS Est. Current Year

-0.740

EPS Est. Next Year

-0.400

EPS Est. Next Quarter

-0.250

Forward EPS

1.#IO

Book Value (p.s.)

17.770

PEG Ratio

Profit Margin

Operating Margin

-56.10

Return on Assets (ttm)

-105.0

Return on Equity (ttm)

96.8

Qtrly Rev. Growth

-13.0

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.057

Qtrly Earnings Growth

Operating Cash Flow (M)

-16.89

Levered Free Cash Flow (M)

-10.93

Valuation

P/E

-1.68

P/E Growth Ratio

-0.04

P/BV

0.07

P/S

20440002.00

P/CF

-1.20

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

1996-03-01

Forward Dividend

Last Split Date

2014-05-23

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.